STI laboratory diagnostics in Europe
This survey was designed to collect information on the laboratory diagnosis of gonorrhoea, chlamydia and syphilis; clinical reporting; laboratory capacity for testing; laboratory accreditation and external quality assessment (EQA); training; reporting and laboratory systems.
A major objective was to enable ECDC to support Member States in providing good quality laboratory surveillance data. The survey has enabled a certain level of laboratory capacity to be established and identified training needs across Europe
ECDC assessed sexually transmitted infections (STI) diagnostic laboratory capacity and training needs across the EU/EEA. The results demonstrate a wide diversity in laboratory work.
Sexual Transmitted Infections (STI) surveillance gathers data on the five STI under surveillance in the European Union and European Economic Area (EU/EEA): syphilis, congenital syphilis, gonorrhoea, chlamydia and lymphogranuloma venereum (LGV). Enhanced surveillance of STI in Europe is essential to provide necessary information to monitor disease distribution and evaluate the public health response to prevent and control the transmission of infections. ECDC strives to ensure a high quality of standardised STI surveillance data, and one way to achieve this is to ensure the laboratory methods used to diagnose cases are of a suitable and recommended standard.
ECDC assessed the level of laboratory capacity and training needs across the EU/EEA with a survey which collected information on the type of laboratory function, diagnostics for chlamydia, gonorrhoea and syphilis, laboratory quality assurance and reporting systems. The main objective was to enable ECDC support to countries in their effort to provide good quality laboratory surveillance data. The survey was performed in 2011 and 44 completed surveys from participating laboratories in 24 EU/EEA countries were received.While an EU-wide mapping of STI laboratory capability was not feasible, the results of the survey demonstrate a wide diversity in laboratory work across the EU/EEA. The low number of national reference laboratories may reflect an area for capacity building in the individual countries, as having a national reference laboratory in each country provides a national centre of expertise.
HIV and men who have sex with men - Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
10 Jan 2020 - This report is part of the 2018 progress reports monitoring the implementation of the Dublin Declaration. It presents the situation among men who have sex with men (MSM), a key group affected by HIV in the WHO European Region, and outlines priorities for action.
ECDC Evidence Brief: Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia
28 Nov 2019 - This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected in 2018 and 2019 by the European Centre for Disease Prevention and Control (ECDC) to monitor implementation of the 2004 Dublin Declaration. The monitoring questionnaire was disseminated to the 53 countries that are part of the WHO European Region, plus Kosovo and Liechtenstein via an online survey.
HIV testing, Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
27 Nov 2019 - This report presents the situation of HIV testing in Europe and Central Asia. It summarises data on implementation of national guidelines that shape HIV testing policies, the provision and uptake of HIV testing services in general and among key populations, and efforts being made to widen engagement with HIV testing and reduce late diagnosis.